Skip to main content
. 2019 Feb 27;16(3):741–760. doi: 10.1007/s13311-019-00719-2

Table 1.

Metabolites significantly different between NS-AL mice, NS-FMD mice, MPTP-AL mice, and MPTP-FMD mice

Metabolite name Group area p value
NS-AL NS-FMD MPTP-AL MPTP-FMD NA vs MA MA vs MF
Nabilone 235,989.146 294,765.137 1,257,579.028 215,382.279 0.000 0.000
(+/-)-C75 680,293.806 517,123.521 1,210,846.783 544,569.239 0.023 0.000
DHODA 327,663.535 532,275.022 877,131.152 462,184.206 0.002 0.019
HMD 53,962.615 62,167.321 86,775.525 68,637.613 0.000 0.012
DD 100,272.217 148,574.161 484,863.732 153,603.871 0.017 0.009
DMTONP 125,426.346 116,370.042 223,137.245 126,821.000 0.038 0.007
DOYOHPG 25,211.672 12,475.515 45,159.253 20,469.442 0.013 0.000
CB 145,833.080 154,221.161 271,099.846 159,665.778 0.013 0.021
Amiloride 238,887.600 307,173.260 354,206.744 263,971.306 0.038 0.041
Isotretinoin 59,463.054 60,938.786 127,714.747 47,842.018 0.023 0.004
OA 1,943,202.465 1,027,283.695 4,580,878.126 671,457.972 0.020 0.000
DA 480,374.351 431,783.114 1,074,167.337 459,382.734 0.028 0.010
Acetylshikonin 19,175.807 14,936.875 130,986.051 54,539.617 0.000 0.000
APM 4,765,796.770 4,623,011.580 6,367,601.718 4,309,795.694 0.022 0.030
Asn-pro 471,638.531 255,744.091 1,683,488.277 204,730.296 0.029 0.000
Butopyronoxyl 398,110.205 430,235.694 246,370.465 379,338.191 0.009 0.002
Azepan-2-one 603,840.601 1,052,156.329 1,358,330.455 655,218.171 0.019 0.031
Capuride 631,293.088 444,456.466 1,513,175.750 597,204.371 0.014 0.012
D-alanyl-D-alanine 87,004.215 70,330.655 162,157.917 41,723.162 0.040 0.000
Dicyclomine 28,386.440 38,897.550 95,167.637 59,070.153 0.001 0.048
Dimetofrine 1,101,806.320 1,218,218.937 1,552,813.269 1,009,942.181 0.000 0.002
DL-glutamine 963,370.395 852,459.578 1,573,320.886 830,824.823 0.041 0.038
Ecgonine 1,050,773.518 1,155,764.435 1,584,894.876 1,320,973.812 0.003 0.022
Fluoxymesterone 169,478.346 126,366.586 285,577.725 69,871.843 0.021 0.000
Gaboxadol 838,644.723 495,145.180 3,587,141.441 431,456.273 0.001 0.000
g-Butyrobetaine 331,073.074 371,449.711 143,574.251 264,044.660 0.003 0.026
Imazapyr 356,735.134 292,676.658 535,542.221 343,288.343 0.048 0.016
Kanosamine 279,368.544 291,453.904 674,447.531 258,624.473 0.025 0.006
L-alanyl-L-proline 455,340.888 598,910.371 2,976,694.869 368,637.531 0.000 0.000
L-alanyl-L-proline 89,073.879 53,265.814 205,415.316 82,780.940 0.044 0.001
CHL 55,659.106 57,587.451 92,877.573 39,122.642 0.023 0.000
TBL 289,761.462 323,549.493 102,525.415 423,331.316 0.003 0.000
DT 434,040.911 426,685.688 782,288.765 429,381.221 0.041 0.007
AG 563,300.118 484,839.231 1,438,941.847 320,271.507 0.006 0.000
N-acetyl-L-histidine 472,083.471 318,819.989 1,027,780.111 430,988.660 0.042 0.026
OM 614,273.359 577,943.473 449,549.780 663,925.220 0.012 0.044
Oxaceprol 252,224.047 290,325.254 535,997.134 293,632.530 0.001 0.001
Oxaceprol 530,732.549 306,802.171 849,670.647 398,505.474 0.023 0.000
PE 1,075,226.380 1,063,171.498 2,396,963.022 979,733.677 0.008 0.000
Acetamide 49,648.898 47,154.069 125,139.271 42,930.012 0.005 0.004
QV1MVO1R 508,324.698 648,284.260 833,894.039 582,818.321 0.000 0.004
Ricinoleic acid 1,332,037.285 1,903,531.420 2,847,023.712 1,188,492.912 0.002 0.000
Ricinoleic acid 246,590.512 241,407.359 572,062.309 267,292.771 0.012 0.023
trans-Anethole 58,787.265 66,823.862 206,866.881 135,176.683 0.000 0.020
UNII:OUT5YHB7BO 87,853.504 99,590.773 166,246.580 82,988.887 0.026 0.000

In all metabolites mentioned above, there is no significant difference of group area between NA group and NF group (p ≥ 0.05). Statistical comparison by one-way ANOVA with post hoc comparisons of LSD

NA = NS-AL group (n = 12); NF = NS-FMD group (n = 18); MA = MPTP-AL group (n = 14); MF = MPTP-FMD group (n = 16); DHODA = 5Z,11beta,13E,15S)-11,15-dihydroxy-N-(2-hydroxyethyl)-9-oxoprosta-5,13-dien-1-amide; HMD = 1-(4-hydroxy-3-methoxyphenyl)-3,5-diacetoxyoctane; DD = 1,1′-[1,12-dodecanediylbis(oxy)]dibenzene; DMTONP = 1,2-dideoxy-3-C-methyl-1-(2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl)pentitol; DOYOHPG = 1-O-[{[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy}(hydroxy)phosphoryl]-beta-D-glucopyranose